Cedars-Sinai Medical Center

Total Awards: 
Award Value: 
Institution type: 
Not for profit
Short Name: 

Awards to the Institution

Program Investigator Award Title Award Value
Early Translational II Dan Gazit Systemic Adult Stem Cell Therapy for Osteoporosis-Related Vertebral Compression Fractures $1,927,698
New Faculty Physician Scientist Robert Baloh Human iPSC modeling and therapeutics for degenerative peripheral nerve disease $3,031,737
Inception - Discovery Stage Research Projects Linda Cambier Exosomal Y-RNAs as mediators of bioactivity of cardiac-derived cell therapy $181,063
Clinical Trial Stage Projects Clive Svendsen CNS10-NPC-GDNF delivered into the motor cortex for the treatment of ALS $11,990,372
Disease Team Research I Eduardo Marbán Autologous cardiac-derived cells for advanced ischemic cardiomyopathy $5,560,232
Early Translational IV Dan Gazit Gene Targeting to Endogenous Stem Cells for Segmental Bone Fracture Healing $5,121,514
Inception - Discovery Stage Research Projects Clive Svendsen Blood Brain Barrier (BBB)-on-Chip: Development and validation of a novel iPS-based microfluidic model of the human BBB $241,992
Research Training Grant Clive Svendsen CIRM Training Program in Translational Regenerative Medicine $4,999,333
Tools and Technologies II Clive Svendsen Use of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy. $1,933,022
Research Leadership Barry Stripp Epithelial progenitors and the stromal niche as therapeutic targets in lung disease $4,841,830
Clinical Trial Stage Projects Michael Lewis Pulmonary Arterial Hypertension Treated with Cardiosphere-Derived Allogeneic Stem Cells $7,354,772
Disease Team Therapy Planning I Dan Gazit Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures. $107,622
Basic Biology V Paul Noble Innate Immune Regulation of Lung Alveolar Stem Cell Renewal in Mouse and Man $617,662
Conference John Yu First Annual Stem Cell Therapies for Neurological Disorders: Overcoming the Current Barriers to Clinical Translation, April 30 (special stem cell program for high school students on April 28) $18,500
Disease Team Therapy Planning I Clive Svendsen Stem Cells Secreting GDNF for the Treatment of ALS $63,487
Disease Team Planning Eduardo Marbán {REDACTED} Heart Disease Regenerative Medicine Team Planning Award $38,980
Conference Clive Svendsen California ALS Summit 2012 $6,825
Disease Team Therapy Development - Research Clive Svendsen Progenitor Cells Secreting GDNF for the Treatment of ALS $16,168,464
Transplantation Immunology Terrence Town Role of HLA in neural stem cell rejection using humanized mice $1,119,385
Clinical Trial Stage Projects Clive Svendsen Human Neural Progenitors Secreting Glial Cell Line-Derived Neurotrophic Factor (CNS10-NPC-GDNF) for the Treatment of Amyotrophic Lateral Sclerosis $6,154,067
iPSC Consortia Award Clive Svendsen The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development $300,000
Late Stage Preclinical Projects Shaomei Wang IND-enabling study of subretinal delivery of human neural progenitor cells for the treatment of retinitis pigmentosa $4,954,514
Inception - Discovery Stage Research Projects Dmitriy Sheyn IVD rejuvenation using iPSC-derived notochordal cells $241,992
Basic Biology IV Eduardo Marbán Mechanism of heart regeneration by cardiosphere-derived cells $1,367,604
SPARK Wafa Tawackoli Mentored High School Summer Research Program $305,281
Clinical Trial Stage Projects Clive Svendsen Clinical Study to Assess Safety and Efficacy of Subretinal Injection of Human Neural Progenitor Cells for Treatment of Retinitis Pigmentosa $10,444,063
Icon for XLSX export